Vitiligo Therapeutics – Pipeline Assessment and Market Forecasts to 2019

2012-02-07
Published : Feb-2012

This report is an essential source of information and analysis on the global Vitiligo Therapeutics market. The report identifies the key trends shaping and driving the global Vitiligo Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Vitiligo Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Vitiligo Therapeutics market. Its scope includes:

  • Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Vitiligo Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
  • Analysis of the current and future competition in the seven key countries Vitiligo Therapeutics market.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Vitiligo Therapeutics market.
  • Analysis of key recent licensing and partnership agreements in Vitiligo Therapeutics market

Reasons to Buy

The report will enhance your decision making capability. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global Vitiligo Therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Vitiligo Therapeutics market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What’s the next big thing in the global Vitiligo Therapeutics market landscape? – Identify, understand and capitalize.

Vitiligo Therapeutics Market

Published:  January 2012
No.OF Pages: 63
Price: Single User License US$ 3995      Corporate User License US$ 11985

Request Sample

Table of Contents

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6

2 Vitiligo Therapeutics – Introduction 7
2.1 Disease Overview 7
2.2 Epidemiology 9
2.3 Etiology and Pathophysiology 9
2.3.1 Etiology of Vitiligo 9
2.3.2 Pathophysiology of Vitiligo 9
2.4 Signs and Symptoms 10
2.5 Diagnosis 11
2.6 Treatment and Management Options 11
2.6.1 Medical Therapies 11
2.6.2 Surgical Therapies 12
2.6.3 Additional Therapies 13
2.7 GlobalData Pipeline Report Guidance 14

3 Vitiligo Therapeutics – Market Characterization 15
3.1 Vitiligo Therapeutics Market Size (2006-2011) – Global 15
3.2 Vitiligo Therapeutics Market Forecast (2011-2019) – Global 17
3.3 Vitiligo Therapeutics Market Size (2006-2011) – The US 18
3.4 Vitiligo Therapeutics Market Forecast (2011-2019) – The US 19
3.5 Vitiligo Therapeutics Market Size (2006-2011) – France 20
3.6 Vitiligo Therapeutics Market Forecast (2011-2019) – France 21
3.7 Vitiligo Therapeutics Market Size (2006-2011) – Germany 22
3.8 Vitiligo Therapeutics Market Forecast (2011-2019) – Germany 23
3.9 Vitiligo Therapeutics Market Size (2006-2011) – Italy 24
3.10 Vitiligo Therapeutics Market Forecast (2011-2019) – Italy 25
3.11 Vitiligo Therapeutics Market Size (2006-2011) – Spain 26
3.12 Vitiligo Therapeutics Market Forecast (2011-2019) – Spain 27
3.13 Vitiligo Therapeutics Market Size (2006-2011) – The UK 28
3.14 Vitiligo Therapeutics Market Forecast (2011-2019) – The UK 29
3.15 Vitiligo Therapeutics Market Size (2006-2011) – Japan 30
3.16 Vitiligo Therapeutics Market Forecast (2011-2019) – Japan 31
3.17 Drivers and Barriers for the Vitiligo Therapeutics Market 32
3.17.1 Drivers for the Vitiligo Therapeutics Market 32
3.17.2 Barriers for the Vitiligo Therapeutics Market 32
3.18 Opportunity and Unmet Need 33
3.19 Key Takeaway 34

4 Vitiligo Therapeutics – Competitive Assessment 35
4.1 Overview 35
4.2 Strategic Competitor Assessment 35
4.3 Product Profile for the Major Marketed Products in the Vitiligo Therapeutics Market 36
4.3.1 Topical Corticosteroids 36
4.3.2 Topical Immunomodulators 37
4.3.3 Methoxsalen 39
4.4 Key Takeaway 39

5 Vitiligo Therapeutics – Pipeline Assessment 40
5.1 Overview 40
5.2 Strategic Pipeline Assessment 40
5.3 Vitiligo Therapeutics – Pipeline Analysis by Clinical Phase of Development 40
5.3.1 Vitiligo Therapeutics – Phase III Clinical Pipeline 41
5.3.2 Vitiligo Therapeutics – Phase II Clinical Pipeline 41
5.3.3 Vitiligo Therapeutics – Preclinical Phase Pipeline 41
5.4 Vitiligo Therapeutics – Pipeline by Mechanism of Action 42
5.5 Technology Trends Analytical Framework 43
5.6 Vitiligo Therapeutics – Most Promising Drugs in Clinical Development 44
5.7 Most Promising Drug Profiles 44
5.7.1 Scenesse (afamelanotide) 44
5.8 Key Takeaway 45

6 Vitiligo Therapeutics – Clinical Trials Mapping 46
6.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 46
6.2 Clinical Trials by Phase of Clinical Development 47
6.3 Clinical Trials by Trial Status 48
6.4 Prominent Sponsors 49
6.5 Clinical Trials by Sponsors 50
6.6 Top Companies Participating in Vitiligo Therapeutics Clinical Trials 50

7 Vitiligo Therapeutics – Strategic Assessment 51
7.1 Key Events Impacting the Future Market 51
7.2 Future Market Competition Scenario 52

8 Vitiligo Therapeutics – Future Players 53
8.1 Introduction 53
8.2 Company Profiles 54
8.2.1 Clinuvel Pharmaceuticals 54
8.2.2 Switch Biotech 55
8.2.3 Dermira 55
8.3 Key Takeaway 56

9 Vitiligo Therapeutics – Licensing & Partnership Deals 57

10 Vitiligo Therapeutics – Appendix 58
10.1 Definitions 58
10.2 Acronyms 58
10.3 Research Methodology 58
10.3.1 Coverage 59
10.3.2 Secondary Research 59
10.3.3 Forecasting 59
10.3.4 Primary Research 61
10.3.5 Expert Panel Validation 62
10.4 Contact Us 62
10.5 Disclaimer 62
10.6 Bibliography 63

1.1 List of Tables & Figures

Filed in: Pharmaceutical
Tags: 
More Reports
Title Price Buy Now

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

“The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......
 $4950

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

“The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......
 $

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

“Digital Pharmacy market to register a CAGR of 17.0%  during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated  to grow at the highest rate during the forecast period” On the basis  ofdrug type, t......
 $4950

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......
 $4950

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases,  growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders,  rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on  product in 2021.” Based on products, the topical drug delivery the market is segmented into ......
 $4950

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

“Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......
 $4950

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......
 $4950

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

“Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......
 $4950

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

“Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......
 $4950

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027

The global Healthcare cloud computing market is projected to reach USD 89.4  billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......
 $4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy